Intracellular lactate-mediated induction of estrogen receptor beta (ERß) in biphasic malignant pleural mesothelioma cells

Arcangela G. Manente, Giulia Pinton, Sara Zonca, Michele Cilli, Maurizio Rinaldi, Antonio Daga, Stefan Nilsson, Laura Moro

Research output: Contribution to journalArticlepeer-review

Abstract

Biphasic malignant pleural mesothelioma (MPM) is the second most common histotype of MPM. It is histologically characterized by the concomitant presence of epithelioid and sarcomatoid features, the latter associated with worse prognosis. In this report we describe that silencing of AKT1 in spindle-shaped biphasic MPM cells promotes the shift toward an epithelioid phenotype. Furthermore, AKT1 silencing resulted in decreased expression of the lactate/H+ symporter MCT4 and its chaperone CD147/Basigin, and in the induction of estrogen receptor ß (ERß) expression. We provide evidence that ERß expression is induced by increased intracellular lactate concentration. Spheroid culturing and tumor growth of ERß negative biphasic MPM in nude mice resulted in the induction of ERß expression and response to the selective agonist KB9520. In both models, the treatment with the ERß agonist results in reduced cell proliferation, decreased expression of MCT4 and CD147/Basigin and increased acetylation and inactivation of AKT1. Collectively, in response to metabolic changes, ERß expression is induced and exerts an anti-tumor effect through selective agonist activation. The possibility to reverse the more aggressive biphasic mesothelioma histotype by targeting ERß with a selective agonist could represent a new effective treatment strategy.

Original languageEnglish
Pages (from-to)25121-25134
Number of pages14
JournalOncotarget
Volume6
Issue number28
DOIs
Publication statusPublished - 2015

Keywords

  • Biphasic pleural mesothelioma
  • Estrogen receptor beta
  • Lactate
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Intracellular lactate-mediated induction of estrogen receptor beta (ERß) in biphasic malignant pleural mesothelioma cells'. Together they form a unique fingerprint.

Cite this